Investigating rates of reoperation or postsurgical gastroparesis following fundoplication or paraesophageal hernia repair in New York State.
Aged
Esophagoplasty
/ adverse effects
Female
Fundoplication
/ adverse effects
Gastroparesis
/ epidemiology
Hernia, Hiatal
/ surgery
Herniorrhaphy
/ adverse effects
Humans
Incidence
Laparoscopy
/ adverse effects
Male
New York
/ epidemiology
Postoperative Complications
/ epidemiology
Reoperation
/ statistics & numerical data
Retrospective Studies
Risk Factors
Fundoplication
Gastroparesis
Paraesophageal hernia repair
Pyloromyotomy
Pyloroplasty
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
07
06
2018
accepted:
09
11
2018
pubmed:
28
11
2018
medline:
6
5
2020
entrez:
28
11
2018
Statut:
ppublish
Résumé
Little is known of the natural history of fundoplication or paraesophageal hernia (PEH) repair in terms of reoperation or the incidence treatment of postsurgical gastroparesis (PSG) in large series. Repeat fundoplications or PEH repairs, as well as pyloroplasty/pyloromyotomy operations, have proven to be effective in the context of PSG or recurrence. In this study, we analyzed the incidences of PSG and risk factors for these revisional surgeries following fundoplication and PEH repair procedures in the state of New York. The New York State Planning and Research Cooperative System (NY SPARCS) database was utilized to examine all adult patients who underwent fundoplication or PEH repair for the treatment of GERD between 2005 and 2010. The primary outcome was the incidence of each type of reoperation and the timing of the follow-up procedure/diagnosis of gastroparesis. Generalized linear mixed models were used to examine the risk factors for follow-up procedures/diagnosis. A total of 5656 patients were analyzed, as 3512 (62.1%) patients underwent a primary fundoplication procedure and 2144 (37.9%) patients underwent a primary PEH repair. The majority of subsequent procedures (n = 254, 65.5%) were revisional procedures (revisional fundoplication or PEH repair) following a primary fundoplication. A total of 134 (3.8%) patients who underwent a primary fundoplication later had a diagnosis of gastroparesis or a follow-up procedure to treat gastroparesis, while 95 (4.4%) patients who underwent a primary PEH repair were later diagnosed with gastroparesis or underwent surgical treatment of gastroparesis. The results revealed low reoperation rates following both fundoplication and PEH repairs, with no significant difference between the two groups. Additionally, PEH repair patients tended to be older and were more likely to have a comorbidity compared to fundoplication patients, particularly in the setting of hypertension, obesity, and fluid and electrolyte disorders. Further research is warranted to better understand these findings.
Sections du résumé
BACKGROUND
Little is known of the natural history of fundoplication or paraesophageal hernia (PEH) repair in terms of reoperation or the incidence treatment of postsurgical gastroparesis (PSG) in large series. Repeat fundoplications or PEH repairs, as well as pyloroplasty/pyloromyotomy operations, have proven to be effective in the context of PSG or recurrence. In this study, we analyzed the incidences of PSG and risk factors for these revisional surgeries following fundoplication and PEH repair procedures in the state of New York.
METHODS
The New York State Planning and Research Cooperative System (NY SPARCS) database was utilized to examine all adult patients who underwent fundoplication or PEH repair for the treatment of GERD between 2005 and 2010. The primary outcome was the incidence of each type of reoperation and the timing of the follow-up procedure/diagnosis of gastroparesis. Generalized linear mixed models were used to examine the risk factors for follow-up procedures/diagnosis.
RESULTS
A total of 5656 patients were analyzed, as 3512 (62.1%) patients underwent a primary fundoplication procedure and 2144 (37.9%) patients underwent a primary PEH repair. The majority of subsequent procedures (n = 254, 65.5%) were revisional procedures (revisional fundoplication or PEH repair) following a primary fundoplication. A total of 134 (3.8%) patients who underwent a primary fundoplication later had a diagnosis of gastroparesis or a follow-up procedure to treat gastroparesis, while 95 (4.4%) patients who underwent a primary PEH repair were later diagnosed with gastroparesis or underwent surgical treatment of gastroparesis.
CONCLUSION
The results revealed low reoperation rates following both fundoplication and PEH repairs, with no significant difference between the two groups. Additionally, PEH repair patients tended to be older and were more likely to have a comorbidity compared to fundoplication patients, particularly in the setting of hypertension, obesity, and fluid and electrolyte disorders. Further research is warranted to better understand these findings.
Identifiants
pubmed: 30478699
doi: 10.1007/s00464-018-6588-z
pii: 10.1007/s00464-018-6588-z
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2886-2894Références
J Clin Endocrinol Metab. 2013 Nov;98(11):E1775-9
pubmed: 24009137
JSLS. 2016 Jan-Mar;20(1):
pubmed: 26884676
JSLS. 2007 Oct-Dec;11(4):456-60
pubmed: 18237510
Surg Endosc. 2018 Jan;32(1):345-350
pubmed: 28707016
Gastroenterol Res Pract. 2009;2009:529802
pubmed: 20224642
Curr Gastroenterol Rep. 2007 Aug;9(4):280-5
pubmed: 17883974
Br J Surg. 1993 Jan;80(1):46-9
pubmed: 8428292
ISRN Gastroenterol. 2012;2012:391631
pubmed: 22844607
Gut. 2005 May;54(5):710-7
pubmed: 15831922
Front Surg. 2015 Apr 20;2:13
pubmed: 25941675
AMIA Jt Summits Transl Sci Proc. 2017 Jul 26;2017:483-492
pubmed: 28815148
Surg Clin North Am. 1992 Apr;72(2):445-65
pubmed: 1549803
Surg Endosc. 2015 Mar;29(3):510-4
pubmed: 24986015
Dig Dis Sci. 1998 Nov;43(11):2398-404
pubmed: 9824125
Gastroenterol Hepatol (N Y). 2017 Feb;13(2):128-129
pubmed: 28450820
Gastroenterology. 2011 Aug;141(2):486-98, 498.e1-7
pubmed: 21684286